Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Use of standardised patients to assess quality of healthcare in Nairobi, Kenya: a pilot, cross-sectional study with international comparisons.

Daniels B, Dolinger A, Bedoya G, Rogo K, Goicoechea A, Coarasa J, Wafula F, Mwaura N, Kimeu R, Das J.

BMJ Glob Health. 2017 Jun 10;2(2):e000333. doi: 10.1136/bmjgh-2017-000333. eCollection 2017.

2.

Observations of infection prevention and control practices in primary health care, Kenya.

Bedoya G, Dolinger A, Rogo K, Mwaura N, Wafula F, Coarasa J, Goicoechea A, Das J.

Bull World Health Organ. 2017 Jul 1;95(7):503-516. doi: 10.2471/BLT.16.179499. Epub 2017 Mar 9.

3.

Examining the Quality of Medicines at Kenyan Healthcare Facilities: A Validation of an Alternative Post-Market Surveillance Model That Uses Standardized Patients.

Wafula F, Dolinger A, Daniels B, Mwaura N, Bedoya G, Rogo K, Goicoechea A, Das J, Olayo B.

Drugs Real World Outcomes. 2017 Mar;4(1):53-63. doi: 10.1007/s40801-016-0100-7.

4.

A concept in flux: questioning accountability in the context of global health cooperation.

Bruen C, Brugha R, Kageni A, Wafula F.

Global Health. 2014 Dec 9;10:73. doi: 10.1186/s12992-014-0073-9.

5.

The policy-practice gap: describing discordances between regulation on paper and real-life practices among specialized drug shops in Kenya.

Wafula F, Abuya T, Amin A, Goodman C.

BMC Health Serv Res. 2014 Sep 16;14:394. doi: 10.1186/1472-6963-14-394.

6.

Implementing Global Fund programs: a survey of opinions and experiences of the Principal Recipients across 69 countries.

Wafula F, Marwa C, McCoy D.

Global Health. 2014 Mar 24;10:15. doi: 10.1186/1744-8603-10-15.

7.

Regional and temporal trends in malaria commodity costs: an analysis of Global Fund data for 79 countries.

Wafula F, Agweyu A, Macintyre K.

Malar J. 2013 Dec 30;12:466. doi: 10.1186/1475-2875-12-466.

8.

Trends in procurement costs for HIV commodities: a 7-year retrospective analysis of global fund data across 125 countries.

Wafula F, Agweyu A, Macintyre K.

J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):e134-9. doi: 10.1097/QAI.0000000000000053.

PMID:
24189152
9.

Protecting the public or setting the bar too high? Understanding the causes and consequences of regulatory actions of front-line regulators and specialized drug shop operators in Kenya.

Wafula F, Molyneux C, Mackintosh M, Goodman C.

Soc Sci Med. 2013 Nov;97:220-7. doi: 10.1016/j.socscimed.2013.08.020. Epub 2013 Aug 27.

10.

Examining characteristics, knowledge and regulatory practices of specialized drug shops in Sub-Saharan Africa: a systematic review of the literature.

Wafula FN, Miriti EM, Goodman CA.

BMC Health Serv Res. 2012 Jul 27;12:223. doi: 10.1186/1472-6963-12-223. Review.

11.

Are interventions for improving the quality of services provided by specialized drug shops effective in sub-Saharan Africa? A systematic review of the literature.

Wafula FN, Goodman CA.

Int J Qual Health Care. 2010 Aug;22(4):316-23. doi: 10.1093/intqhc/mzq022. Epub 2010 Apr 29. Review.

Supplemental Content

Loading ...
Support Center